FI844185L - N-substituerade isokinolinderivat och foerfarande foer framstaellning daerav. - Google Patents

N-substituerade isokinolinderivat och foerfarande foer framstaellning daerav.

Info

Publication number
FI844185L
FI844185L FI844185A FI844185A FI844185L FI 844185 L FI844185 L FI 844185L FI 844185 A FI844185 A FI 844185A FI 844185 A FI844185 A FI 844185A FI 844185 L FI844185 L FI 844185L
Authority
FI
Finland
Prior art keywords
alkyl
carbon atoms
phenyl
isokinolinderivat
substituerade
Prior art date
Application number
FI844185A
Other languages
English (en)
Other versions
FI79533B (fi
FI844185A0 (fi
FI79533C (fi
Inventor
Gabor Bernath
Jenoe Kobor
Ferenc Fueloep
Pal Perjesi
Elemer Ezer
Gyoergy Hajos
Eva Palosi
Laszlo Denes
Laszlo Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of FI844185A0 publication Critical patent/FI844185A0/fi
Publication of FI844185L publication Critical patent/FI844185L/fi
Publication of FI79533B publication Critical patent/FI79533B/fi
Application granted granted Critical
Publication of FI79533C publication Critical patent/FI79533C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI844185A 1983-10-25 1984-10-25 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-substituerade isokinolinderivat. FI79533C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU365283 1983-10-25
HU833652A HU189765B (en) 1983-10-25 1983-10-25 Process for preparing n-substituted 1-(bis (hydroxy-metiol)-methyl)-isoquinoline-derivatives

Publications (4)

Publication Number Publication Date
FI844185A0 FI844185A0 (fi) 1984-10-25
FI844185L true FI844185L (fi) 1985-04-26
FI79533B FI79533B (fi) 1989-09-29
FI79533C FI79533C (fi) 1990-01-10

Family

ID=10964925

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844185A FI79533C (fi) 1983-10-25 1984-10-25 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-substituerade isokinolinderivat.

Country Status (9)

Country Link
US (1) US4668688A (fi)
EP (1) EP0142740B1 (fi)
JP (1) JPS60132962A (fi)
AT (1) ATE35133T1 (fi)
CA (1) CA1265141A (fi)
DE (1) DE3472104D1 (fi)
DK (1) DK508484A (fi)
FI (1) FI79533C (fi)
HU (1) HU189765B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5360568A (en) * 1993-11-12 1994-11-01 Lever Brothers Company, Division Of Conopco, Inc. Imine quaternary salts as bleach catalysts
WO1995013352A1 (en) * 1993-11-12 1995-05-18 Unilever N.V. Imine quaternary salts as bleach catalysts
US5360569A (en) * 1993-11-12 1994-11-01 Lever Brothers Company, Division Of Conopco, Inc. Activation of bleach precursors with catalytic imine quaternary salts
CA2673683C (en) 2007-01-11 2014-07-29 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
CA2710039C (en) 2007-12-26 2018-07-03 Critical Outcome Technologies, Inc. Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer
WO2010006438A1 (en) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199775B (de) * 1960-04-01 1965-09-02 Hoffmann La Roche Verfahren zur Herstellung von analgetisch, hustenlindernd und spasmolytisch wirksamenTetrahydroisochinolinderivaten
US3562280A (en) * 1967-08-30 1971-02-09 Hoffmann La Roche Substituted 1,2,3,4-tetrahydroisoquinolines
DD121321A1 (fi) * 1975-04-24 1976-07-20
HU178454B (en) * 1979-07-02 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new isoquinoline derivatives containing sulphur

Also Published As

Publication number Publication date
FI79533B (fi) 1989-09-29
FI844185A0 (fi) 1984-10-25
DE3472104D1 (en) 1988-07-21
EP0142740A1 (en) 1985-05-29
CA1265141A (en) 1990-01-30
FI79533C (fi) 1990-01-10
ATE35133T1 (de) 1988-07-15
EP0142740B1 (en) 1988-06-15
HU189765B (en) 1986-07-28
JPS60132962A (ja) 1985-07-16
DK508484A (da) 1985-04-26
DK508484D0 (da) 1984-10-25
US4668688A (en) 1987-05-26

Similar Documents

Publication Publication Date Title
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR860005794A (ko) 이미다졸 유도체의 제조방법
BR8901097A (pt) Processo para a preparacao de uma composicao biocida
PT90021A (pt) Processo para a preparacao de derivados de benzofenona
FI844185L (fi) N-substituerade isokinolinderivat och foerfarande foer framstaellning daerav.
KR910016710A (ko) 4-페닐프탈라진 유도체
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
ES8503333A1 (es) Un metodo de preparar derivados de 4-quinolona
DK406084A (da) Cephalosporinderivater og fremgangsmaade til deres fremstilling
DE69023939D1 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
ES2038794T3 (es) Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen.
DK412581A (da) Ethenylimidazolderivater og fremgangsmaade til fremstilling heraf
ES531933A0 (es) Un procedimiento para preparar un derivado de imidazolinona
SE7612685L (sv) Forfarande for framstellning av nya imidazolforeningar
SE8505369L (sv) Nya tienopyridinderivat, ett forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
FI844186A0 (fi) Bis(substituerad metyl) -metylisokinolinderivat och foerfarande foer framstaellning daerav.
FI844184A0 (fi) Isokinolinderivat och foerfarande foer framstaellning daerav.
KR870001223A (ko) 포스페이트 에스테르 유도체의 제조방법
KR880009906A (ko) 신규한 제초 화합물과 그 제조방법 및 이를 포함하는 제초조성물
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
SE8000138L (sv) Nya 3-cyklopentan-1,2'(1'h)-naftalen-derivat, framstellning derav och lekemedel innehallande desamma
FR2550189B1 (fr) Nouveaux derives acetyleniques possedant une activite d'inhibiteurs d'enzyme, leur preparation et leur application comme medicament
FI893051A (fi) Oxiraner.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RICHTER GEDEON VEGYESZETI GYAR R.T.